GSK's pivotal AZUR-1 trial of cancer immunotherapy Jemperli, as a way to delay or eliminate surgery in pre-operative rectal ...

Apnimed has joined the IPO queue on the Nasdaq, hoping to raise additional funding for its late-stage oral therapy for ...

Hundreds of researchers at the Institute of Cancer Research (ICR) in London have held historic strikes across sites in Sutton ...

Organisations are beginning to rethink field integration more holistically out of a realisation that consistency in ...

A large-scale trial has been launched, with $100 million in backing, to explore whether lifestyle changes coupled with GLP-1 ...

EU pharmaceutical safety advisers have said that commonly used contraceptives may carry a small risk of a type of brain ...

Island Pharma has been granted the regulatory approvals needed to allow compassionate use of its antiviral galidesivir in the Bundibugyo Ebola outbreak in Uganda. The Melbourne, Australia-based ...

Vertex Pharma has made the largest acquisition in its history, agreeing to buy Crinetics Pharma for around $10 billion in a ...

Bayer has partnered with private equity group Apollo to set up a new entity that will handle its long-acting contraceptive ...

Eyecare company Bausch + Lomb has had a hole blown in its pharma pipeline, after disappointing trial results forced it to ...

Shares in AstraZeneca were trading down more than 8% this morning after it revealed that its transthyretin amyloidosis (ATTR) ...